Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Salarius Pharmaceuticals, Inc. (SLRX)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
7 Jun 2022
Burleson Tess
Director
Salarius Pharmaceuticals, Inc.
(SLRX)
32,050
+636%
27,700
$0.18
$4,986.00
BUY
7 Jun 2022
Lieber Jonathan I
Director
Salarius Pharmaceuticals, Inc.
(SLRX)
37,500
+100%
37,500
$0.19
$7,016.25
BUY
6 Jun 2022
McVicar William K.
Director
Salarius Pharmaceuticals, Inc.
(SLRX)
26,553
+100%
26,553
$0.19
$4,999.93
BUY
3 Jun 2022
HANISH ARNOLD C
Director
Salarius Pharmaceuticals, Inc.
(SLRX)
46,350
+152%
28,000
$0.18
$5,152.00
BUY
31 May 2022
Rosenblum Mark J
Exec VP Finance, CFO, Officer
Salarius Pharmaceuticals, Inc.
(SLRX)
148,319
+23%
28,000
$0.18
$5,040.00
BUY
26 May 2022
Arthur David J.
Chief Executive Officer, Director, Officer
Salarius Pharmaceuticals, Inc.
(SLRX)
263,074
+20%
43,900
$0.18
$7,984.60
BUY
3 Mar 2022
Rosenblum Mark J
Exec VP Finance, CFO, Officer
Salarius Pharmaceuticals, Inc.
(SLRX)
110,319
+223%
76,246
$0.39
$29,812.19
BUY
3 Mar 2022
Arthur David J.
Chief Executive Officer, Director, Officer
Salarius Pharmaceuticals, Inc.
(SLRX)
249,674
+126%
139,488
$0.39
$54,539.81
BUY
17 Aug 2021
Arthur David J.
Chief Executive Officer, Director, Officer
Salarius Pharmaceuticals, Inc.
(SLRX)
100,247
+4%
4,000
$0.90
$3,582.00
BUY
10 Aug 2021
HANISH ARNOLD C
Director
Salarius Pharmaceuticals, Inc.
(SLRX)
18,350
+61%
7,000
$0.88
$6,167.00
BUY
21 Aug 2020
HANISH ARNOLD C
Director
Salarius Pharmaceuticals, Inc.
(SLRX)
11,350
+54%
4,000
$0.98
$3,920.00
BUY
19 Aug 2020
Arthur David J.
Chief Executive Officer, Director, Officer
Salarius Pharmaceuticals, Inc.
(SLRX)
1,000
+200%
2,000
$1.01
$2,020.00
BUY
17 Aug 2020
Rosenblum Mark J
Exec VP Finance, CFO, Officer
Salarius Pharmaceuticals, Inc.
(SLRX)
12,000
+71%
5,000
$1.00
$5,000.00
BUY
19 Feb 2020
Rosenblum Mark J
Exec VP Finance, CFO, Officer
Salarius Pharmaceuticals, Inc.
(SLRX)
7,000
+40%
2,000
$0.95
$1,900.00
BUY
18 Feb 2020
Jordan Scott
Chief Business Officer, Officer
Salarius Pharmaceuticals, Inc.
(SLRX)
31,609
+55%
11,300
$0.90
$10,170.00
BUY
13 Feb 2020
Rosenblum Mark J
Exec VP Finance, CFO, Officer
Salarius Pharmaceuticals, Inc.
(SLRX)
5,000
+100%
5,000
$0.86
$4,295.00
BUY
11 Feb 2020
Arthur David J.
Chief Executive Officer, Director, Officer
Salarius Pharmaceuticals, Inc.
(SLRX)
81,546
+2%
2,175
$1.15
$2,501.25
BUY
11 Feb 2020
HANISH ARNOLD C
Director
Salarius Pharmaceuticals, Inc.
(SLRX)
7,350
+145%
4,350
$1.15
$5,002.50
BUY
11 Feb 2020
McCreedy Bruce J Jr.
Director
Salarius Pharmaceuticals, Inc.
(SLRX)
8,700
+100%
8,700
$1.15
$10,005.00
BUY
11 Feb 2020
McVicar William K.
Director
Salarius Pharmaceuticals, Inc.
(SLRX)
8,700
+100%
8,700
$1.15
$10,005.00
BUY
11 Feb 2020
Northrup Jonathan P
Director
Salarius Pharmaceuticals, Inc.
(SLRX)
352,713
+2%
8,700
$1.15
$10,005.00
BUY
11 Feb 2020
Burleson Tess
Director
Salarius Pharmaceuticals, Inc.
(SLRX)
4,350
+100%
4,350
$1.15
$5,002.50
BUY
25 Nov 2019
HANISH ARNOLD C
Director
Salarius Pharmaceuticals, Inc.
(SLRX)
6,000
+100%
3,000
$3.59
$10,770.00
SELL
9 Jan 2019
Boston Foundation, Inc.
10% Owner
Flex Pharma, Inc.
(FLKS)
1,600,000
-0%
13,480
$9.19
$123,847.50
SELL
8 Jan 2019
Boston Foundation, Inc.
10% Owner
Flex Pharma, Inc.
(FLKS)
1,937,000
-0%
10,520
$9.92
$104,305.81
SELL
16 Oct 2018
Longwood Fund II, L.P.
10% Owner
Flex Pharma, Inc.
(FLKS)
0
-100%
128,514.44
$22.89
$2,941,053.00
SELL
16 Oct 2018
Westphal Christoph H
10% Owner
Flex Pharma, Inc.
(FLKS)
0
-100%
128,514.44
$22.89
$2,941,053.00
BUY
8 Nov 2016
Westphal Christoph H
President and CEO, Director, Officer, 10% Owner
Flex Pharma, Inc.
(FLKS)
3,941,118
+0%
280
$182.75
$51,170.00
BUY
7 Nov 2016
Westphal Christoph H
President and CEO, Director, Officer, 10% Owner
Flex Pharma, Inc.
(FLKS)
3,934,118
+0%
354.8
$142.50
$50,559.00
BUY
7 Nov 2016
McCabe John P.
VP of Finance & Treasurer, Officer
Flex Pharma, Inc.
(FLKS)
1,650
+4%
66
$150.25
$9,916.50
BUY
23 Jun 2016
Westphal Christoph H
President and CEO, Director, Officer, 10% Owner
Flex Pharma, Inc.
(FLKS)
3,212,861
+0%
108
$282.00
$30,456.00
BUY
21 Jun 2016
Westphal Christoph H
President and CEO, Director, Officer, 10% Owner
Flex Pharma, Inc.
(FLKS)
3,210,161
+0%
228
$276.24
$62,983.00
BUY
17 Jun 2016
Westphal Christoph H
President and CEO, Director, Officer, 10% Owner
Flex Pharma, Inc.
(FLKS)
3,204,461
+0%
240
$279.38
$67,050.00
BUY
15 Jun 2016
Westphal Christoph H
President and CEO, Director, Officer, 10% Owner
Flex Pharma, Inc.
(FLKS)
3,198,461
+0%
232
$279.25
$64,786.00
BUY
13 Jun 2016
Westphal Christoph H
President and CEO, Director, Officer, 10% Owner
Flex Pharma, Inc.
(FLKS)
3,192,661
+0%
236
$288.47
$68,080.00
BUY
9 Jun 2016
Westphal Christoph H
President and CEO, Director, Officer, 10% Owner
Flex Pharma, Inc.
(FLKS)
3,186,761
+0%
240
$298.38
$71,610.00
BUY
7 Jun 2016
Westphal Christoph H
President and CEO, Director, Officer, 10% Owner
Flex Pharma, Inc.
(FLKS)
3,180,761
+0%
236
$306.25
$72,276.00
BUY
3 Jun 2016
Westphal Christoph H
President and CEO, Director, Officer, 10% Owner
Flex Pharma, Inc.
(FLKS)
3,174,861
+0%
240
$314.00
$75,360.00
BUY
1 Jun 2016
Westphal Christoph H
President and CEO, Director, Officer, 10% Owner
Flex Pharma, Inc.
(FLKS)
3,168,861
+0%
400
$324.75
$129,900.00
BUY
27 May 2016
Westphal Christoph H
President and CEO, Director, Officer, 10% Owner
Flex Pharma, Inc.
(FLKS)
3,158,861
+0%
892
$316.89
$282,664.00
BUY
25 May 2016
Westphal Christoph H
President and CEO, Director, Officer, 10% Owner
Flex Pharma, Inc.
(FLKS)
3,136,561
+0%
1,144
$320.99
$367,214.00
BUY
23 May 2016
Westphal Christoph H
President and CEO, Director, Officer, 10% Owner
Flex Pharma, Inc.
(FLKS)
3,107,961
+0%
1,213.36
$310.41
$376,635.28
BUY
19 May 2016
Westphal Christoph H
President and CEO, Director, Officer, 10% Owner
Flex Pharma, Inc.
(FLKS)
3,077,627
+0%
316.56
$276.39
$87,494.00
BUY
17 May 2016
Westphal Christoph H
President and CEO, Director, Officer, 10% Owner
Flex Pharma, Inc.
(FLKS)
3,069,713
+0%
1,336
$277.48
$370,708.00
BUY
13 May 2016
Westphal Christoph H
President and CEO, Director, Officer, 10% Owner
Flex Pharma, Inc.
(FLKS)
3,036,313
+0%
618.76
$256.36
$158,624.22
BUY
11 May 2016
Westphal Christoph H
President and CEO, Director, Officer, 10% Owner
Flex Pharma, Inc.
(FLKS)
3,020,844
+0%
1,208.68
$253.06
$305,863.75
BUY
9 May 2016
Westphal Christoph H
President and CEO, Director, Officer, 10% Owner
Flex Pharma, Inc.
(FLKS)
2,990,627
+0%
1,204.36
$248.55
$299,344.38
BUY
23 Mar 2016
Westphal Christoph H
President and CEO, Director, Officer, 10% Owner
Flex Pharma, Inc.
(FLKS)
2,960,518
+0%
1,982.52
$276.54
$548,245.70
BUY
21 Mar 2016
Westphal Christoph H
President and CEO, Director, Officer, 10% Owner
Flex Pharma, Inc.
(FLKS)
2,887,004
+0%
1,922.32
$293.50
$564,194.70
BUY
18 Mar 2016
SCULLEY JOHN
Director
Flex Pharma, Inc.
(FLKS)
4,709
+4%
188.36
$298.00
$56,131.17
BUY
17 Mar 2016
Westphal Christoph H
President and CEO, Director, Officer, 10% Owner
Flex Pharma, Inc.
(FLKS)
2,862,897
+0%
1,502.96
$274.97
$413,272.00
BUY
15 Mar 2016
Stacy Michelle
Director
Flex Pharma, Inc.
(FLKS)
2,585
+4%
103.4
$240.75
$24,893.55
BUY
15 Mar 2016
Westphal Christoph H
President and CEO, Director, Officer, 10% Owner
Flex Pharma, Inc.
(FLKS)
2,825,323
+0%
1,535.16
$255.84
$392,750.62
BUY
11 Mar 2016
Longwood Fund II, L.P.
10% Owner
Flex Pharma, Inc.
(FLKS)
2,786,944
+0%
3,587.2
$175.00
$627,760.00
BUY
11 Mar 2016
Westphal Christoph H
President and CEO, Director, Officer, 10% Owner
Flex Pharma, Inc.
(FLKS)
2,786,944
+0%
3,587.2
$175.00
$627,760.00
BUY
11 Mar 2016
Wessel Thomas
Chief Medical Officer, Officer
Flex Pharma, Inc.
(FLKS)
57,064
+1%
800
$198.55
$158,840.00
BUY
11 Mar 2016
MacKinnon Roderick
Director
Flex Pharma, Inc.
(FLKS)
431,277
+0%
400
$175.65
$70,261.00
Home